SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-216973
Filing Date
2020-08-12
Accepted
2020-08-12 06:54:56
Documents
17
Period of Report
2020-08-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d40650d8k.htm   iXBRL 8-K 54904
2 EX-2.1 d40650dex21.htm EX-2.1 590162
3 EX-10.1 d40650dex101.htm EX-10.1 44501
4 EX-10.2 d40650dex102.htm EX-10.2 14461
5 EX-99.1 d40650dex991.htm EX-99.1 19685
9 GRAPHIC g40650111.jpg GRAPHIC 10385
  Complete submission text file 0001193125-20-216973.txt   1037933

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA cbmg-20200811.xsd EX-101.SCH 3078
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbmg-20200811_lab.xml EX-101.LAB 18138
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbmg-20200811_pre.xml EX-101.PRE 11413
10 EXTRACTED XBRL INSTANCE DOCUMENT d40650d8k_htm.xml XML 3357
Mailing Address 209 PERRY PARKWAY SUITE 13 GAITHERSBURG MD 20877
Business Address 209 PERRY PARKWAY SUITE 13 GAITHERSBURG MD 20877 (301) 825 5320
Cellular Biomedicine Group, Inc. (Filer) CIK: 0001378624 (see all company filings)

IRS No.: 861032927 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36498 | Film No.: 201094047
SIC: 2836 Biological Products, (No Diagnostic Substances)